| metastatic/adv melanoma (mML) | |
| mML - NA - all population | |
| anti-PD-(L)1 | |
| nivolumab based treatment | |
| nivolumab alone | IMMUNED ... CheckMate 238 |
| pembrolizumab based treatment | |
| pembrolizumab alone | KEYNOTE 054 ... |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-